34 studies found for:    "Dementia With Lewy Bodies"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Imaging of Vesicular Acetylcholine and Dopamine Transporters in Dementia With Lewy Bodies
Condition: Dementia With Lewy Bodies
Interventions: Other: Imaging with IBVM;   Other: Imaging with DATSCAN;   Behavioral: neuropsychological evaluation
2 Completed Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy Bodies
Conditions: Parkinson's Disease Dementia;   Dementia With Lewy Bodies
Interventions: Drug: Memantine;   Drug: Placebo
3 Active, not recruiting A Study of E2020 in Patients With Dementia With Lewy Bodies (DLB), Followed by a Long-term Extension Phase
Condition: Dementia With Lewy Bodies (DLB)
Interventions: Drug: E2020;   Drug: Placebo
4 Recruiting Effects of Nucleus Basalis of Meynert Stimulation on Cognitive Disorders in Dementia With Lewy Bodies
Condition: Dementia With Lewy Bodies
Intervention: Procedure: Electrical stimulation of the nucleus basalis of Meynert
5 Completed "Pilot Study of Armodafinil in Patients With Dementia With Lewy Bodies"
Condition: Dementia With Lewy Bodies
Intervention: Drug: Armodafinil
6 Completed Efficacy and Safety of Memantine for Parkinson's Disease Dementia (PDD) and Dementia With Lewy Bodies (DLB)
Conditions: Dementia Associated With Parkinson's Disease;   Dementia With Lewy Bodies
Interventions: Drug: Memantine;   Drug: Placebo
7 Completed A Long-term, Extension Study of E2020 in Patients With Dementia With Lewy Bodies
Condition: Dementia With Lewy Bodies (DLB)
Intervention: Drug: E2020 (Aricept)
8 Completed Safety and Efficacy of Galantamine in Patients With Dementia With Lewy Bodies
Condition: Lewy Body Disease
Intervention: Drug: Galantamine
9 Completed
Has Results
A Double-blind Study of E2020 (Donepezil Hydrochloride) in Patients With Dementia With Lewy Bodies (DLB) (Study E2020-J081-431)
Condition: Dementia With Lewy Bodies (DLB)
Interventions: Drug: 3 mg Donepezil hydrochloride;   Drug: 5 mg Donepezil hydrochloride;   Drug: 10 mg Donepezil hydrochloride;   Drug: Placebo
10 Recruiting Donepezil Therapy and Changes of Symptoms and Glucose Metabolism in Patients With Dementia With Lewy Bodies (DLB)
Condition: Dementia With Lewy Bodies (DLB)
Intervention: Drug: Donepezil
11 Recruiting Alpha-synuclein in Cerebrospinal Fluid to Differentiate Alzheimer's Disease From Lewy Body Disease.
Condition: "Alzheimer's Disease" and "Lewy Body Disease"
Interventions: Other: MRI;   Procedure: lumbar puncture;   Behavioral: neuropsychological tests
12 Unknown  Attention Modulation for Treatment of Parkinson's Disease and Dementia With Lewy Bodies
Conditions: Parkinsons Disease;   Lewy Bodies Disease
Intervention: Drug: Armodafinil
13 Completed Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia
Conditions: Lewy Body Dementia;   Non-DLB Dementia;   Alzheimer’s;   Vascular Dementia
Intervention: Drug: DatSCAN
14 Completed A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET)
Conditions: Dementia With Lewy Bodies;   Alzheimer's Disease;   Parkinson's Disease
Interventions: Drug: 18F-AV-133;   Drug: 18F-AV-45
15 Recruiting Oculomotor Testing in the Differential Diagnosis of Dementia
Conditions: Lewy Body Disease;   Alzheimer's Disease
Intervention: Other: oculomotor measurements
16 Completed Diagnostic of Lewy Body Dementia by Combining Scintigraphy (SPECT) Using a Specific Transporter and Magnetic Resonance Imaging (MRI)
Condition: Lewy Body Dementia
Intervention: Procedure: Single photon emission computed tomography and Magnetic Resonance Imaging
17 Withdrawn Treating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With Ramelteon
Conditions: Huntington's Disease;   Parkinson's Disease;   Dementia With Lewy Bodies;   Sleep Disorders;   Circadian Dysregulation
Interventions: Drug: Ramelteon;   Drug: Placebo
18 Unknown  Assessment of Social-emotional Functioning in Neurological Diseases
Conditions: Alzheimer Disease;   Stroke;   Parkinson's Disease;   Lewy Body Dementia;   Huntington Disease
Intervention: Behavioral: Computerized tests and Electrophysiological measurements
19 Enrolling by invitation DaTSCAN Imaging in Aging and Neurodegenerative Disease
Conditions: Dementia;   Parkinsonism;   Mild Cognitive Impairment
Interventions: Drug: DaTscan;   Device: Single photon emission computed tomography (SPECT) scan
20 Completed Research of Biomarkers in Parkinson Disease
Conditions: Parkinson Disease;   Multiple System Atrophy;   Progressive Supranuclear Palsy;   Huntington Disease;   Dystonia;   Diffuse Lewy Body Disease
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-34) Show next page of results
Indicates status has not been verified in more than two years